We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Drug Discovery

Drug Discovery

Stay up to date on the topics that matter to you

Trending News

A blue beetle.

First Use of CRISPR-Cas9 Gene Editing in Kissing Bugs

Protein structures.

Scientists Uncover the Cellular Functions of Proteins Integral to Inflammatory Diseases

Two hands holding up a nasal spray, a packet of white pills and a tissue.

Common Antibiotic Shows Promise in the Treatment of Respiratory Viral Infections

Rice Bran Nanoparticles Show Promise as Anti-Cancer Agent

Study Investigates How Aspirin Helps To Prevent Colorectal Cancer Development

Fibrin Immunotherapy’s Potential for Treating Traumatic Brain Injury

News

Vetter Serializes the First Product for South Korea

CDMO produces clearly identifiable labelling for a top-ten pharmaceutical company.

TxCell Appoints Stéphane Boissel as Chief Executive Officer

Company promotes Miguel Forte to Chief Operating Officer.

Luminex Corporation Provides Updates on ARIES® Clinical Trials

Clinical trials initiated for ARIES® Clostridium difficile assay.

Debiopharm Initiates Clinical Phase II Study to Evaluate Debio 1450

One year after the initiation of Phase I, Debiopharm has announced the start of clinical phase II for Debio 1450 in ABSSSI and presentation of new data at ECCMID.

TxCell and Trizell Amend Collaboration Agreement

Company appoints the Cell Therapy Catapult to perform process and manufacturing development.

ELC Group Signs 1.5 Million Euro Regulatory Affairs Contract

Landmark deal ELC Group’s Concept to Commercialization solution approach.

Mitotech Announces Phase 2 Data Showing Positive Effect of SkQ1

Company to initiate a Phase III trial in Q4 2015.

Intercept Announces New FLINT Trial Data

Data showing OCA treatment increases fibrosis resolution and cirrhosis prevention in high-risk NASH patients.

Alcoholic Hepatitis Treatments Fail to Keep Patients Alive

The study is published in the New England Journal of Medicine.

Optivia and Hurel Form Technology and Marketing Alliance

Firms partner to improve understanding of in vitro/in vivo correlation for transporter-mediated hepatic clearance, drug-drug interactions, and drug-induced liver injury.

Advertisement

Advertisement

Decoratvive background images

Never miss a story

with the Breaking Science News daily newsletter